x min read

Trader's Watch List: CEL-SCI Corporation (NYSEMKT:CVM), Regions Financial Corporation (NYSE:RF), Kohl's Corp. (NYSE:KSS), Genomic Health Inc. (NASDAQ:GHDX), E-House (China) Holdings Limited (NYSE:EJ)

Trader's Watch List: CEL-SCI Corporation (NYSEMKT:CVM), Regions Financial Corporation (NYSE:RF), Kohl's Corp. (NYSE:KSS), Genomic Health Inc. (NASDAQ:GHDX), E-House (China) Holdings Limited (NYSE:EJ)
Written by
Charles Donlon
Published on
November 14, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

CEL-SCI Corporation (NYSE MKT:CVM) today announced that during the month of October the Company enrolled 22 patients with advanced primary not yet treated head and neck cancer into its global pivotal Phase III head and neck cancer trial for its investigational immunotherapy Multikine* (Leukocyte Interleukin Injection). This brings the total number patients enrolled in the world’s largest Phase III trial for head and neck cancer to almost 300. A total of 880 patients are expected to be enrolled through 100 clinical centers in over 20 countries. CEL-SCI Corporation (NYSEMKT:CVM) belongs to Healthcare sector. Its weekly performance is -6.15%. On last trading day company shares ended up $0.61. CEL-SCI Corporation (NYSEMKT:CVM) distance from 50-day simple moving average (SMA50) is -24.78%. Regions Bank (NYSE:RF) customers can now take advantage of Apple Pay, an innovative, safe and convenient way of making purchases. Regions now offers debit, consumer credit and reloadable prepaid card customers access to Apple Pay. Regions Financial Corporation (NYSE:RF) shares fell -0.39% in last trading session and ended the day at $10.17. RF return on assets is 1.00%. Regions Financial Corporation (NYSE:RF) quarterly performance is 4.52%. Kohl's Corp. (NYSE:KSS) stock is heading south after the department store chain reported a fiscal third-quarter profit that fell short of expectations. On 13 November, Kohl's Corp. (NYSE:KSS) shares fell -3.18% and was closed at $56.07. KSS EPS growth in last 5 year was 7.70%. Kohl's Corp. (NYSE:KSS) year to date (YTD) performance is 0.88%. Genomic Health (NASDAQ:GHDX) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.02. The company had revenue of $69.10 million for the quarter, compared to the consensus estimate of $71.00 million. During the same quarter in the previous year, the company posted $0.02 earnings per share. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. On average, analysts predict that Genomic Health will post $-0.80 earnings per share for the current fiscal year. Genomic Health Inc. (NASDAQ:GHDX) ended the last trading day at $32.77. Company weekly volatility is calculated as 4.80% and price to cash ratio as 9.83. Genomic Health Inc. (NASDAQ:GHDX) showed a weekly performance of -6.61%. E-House (China) Holdings Limited (ADR) (NYSE:EJ) announced that it will report its unaudited financial results for the third quarter ended September 30, 2014 before the U.S. markets open on November 19, 2014. E-House (China) Holdings Limited (ADR) (NYSE:EJ) shares fell -3.52% in last trading session and ended the day at $9.59. EJ Gross Margin is 63.90% and its return on assets is 4.30%. E-House (China) Holdings Limited (ADR) (NYSE:EJ) quarterly performance is -17.18%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.